Study guide
17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT)
IJCAHPO Certified Ophthalmic Medical Technologist COMT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements
1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification
2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology
2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway
3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety
3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety
4 Chapter 4: Ophthalmic History Taking & Clinical Documentation
4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record
5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision
5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction
6 Chapter 6: Tonometry, Keratometry & Pupil Measurement
6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria
7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis
7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment
8 Chapter 8: Refraction, Retinoscopy & Refinement
8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations
9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics
9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations
10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy
10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training
11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation
11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing
12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique
12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics
13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials
14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)
14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics
15 Chapter 15: Fluorescein Angiography Principles & Technique
15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management
16 Chapter 16: Angiographic Interpretation & Pathology
16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology
17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography
17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers
18 Chapter 18: Ophthalmic Photography & Videography
18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management
19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)
19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging
20 Chapter 20: Biometry, Topography & Corneal Analysis
20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth
21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting
21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems
22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications
22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis
23 Chapter 23: Ocular Pharmacology
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF
24 Chapter 24: Microbiology & Ocular Specimen Collection
24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection
25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery
25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery
26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol
27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures
27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)
28 Chapter 28: Ophthalmic Patient Services & Education
28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support
29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance
29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements
17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT)
Key Takeaways Explain This Topic AI
Enhanced Depth Imaging (EDI-OCT) shifts the instrument's zero-delay reference line to the chorio-scleral interface, maximizing signal-to-noise ratio in the choroid and lamina cribrosa without hardware changes.
Normal subfoveal choroidal thickness (SFCT) averages ~250–350 µm in healthy adults, undergoing ~15–20 µm thinning per decade of life, and markedly exceeding 390–400 µm in the pachychoroid disease spectrum.
EDI-OCT is essential for distinguishing choroidal nevi from malignant melanomas based on the TFSOM-UHHD criteria, resolving subretinal fluid, thickness, and acoustic shadowing.
Anterior Segment OCT (AS-OCT) employs longer near-infrared wavelengths (~1310 nm) to minimize optical scattering in opaque sclera and edematous corneas.
Quantitative AS-OCT angle metrics—Angle Opening Distance (AOD500/750) and Trabecular-Iris Space Area (TISA500/750)—objectively classify pupillary block, plateau iris configuration, and excessive lens vault.
Last updated: September 2026
Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT)
Clinical Core: Enhanced Depth Imaging (EDI-OCT) transforms standard spectral-domain platforms by shifting the zero-delay line closer to the chorio-scleral interface, enabling precise quantification of subfoveal choroidal thickness and deep lamina cribrosa pores. In parallel, Anterior Segment OCT (AS-OCT) leverages a longer ~1310 nm wavelength to penetrate opaque sclera and edematous corneas, providing objective biometry of anterior chamber angles, angle-closure mechanisms, and lamellar graft interfaces.
Biophysical Principles of Enhanced Depth Imaging (EDI-OCT)
In conventional Spectral-Domain OCT imaging, sensitivity and optical signal-to-noise ratio (SNR) are not uniform across the imaging depth. The instrument's highest sensitivity lies directly at the zero delay line (the plane where the sample and reference arm optical paths are identical). In standard retinal OCT modes:
The zero-delay line is positioned in the vitreous cavity above the retina.
Because spectrometer resolution is limited by pixel cross-talk and finite detector elements, sensitivity exhibits a steep drop-off ( sensitivity roll-off ) as imaging depth increases away from the zero-delay line.
Consequently, deep structures such as the outer choroid, choriocapillaris, and lamina cribrosa suffer from weak backscattering, poor SNR, and obscured anatomical margins.
The EDI Optical Technique
Enhanced Depth Imaging overcomes this limitation without modifying the underlying spectrometer hardware:
Instrument Displacement: The technologist moves the OCT objective lens slightly closer to the patient's cornea than in conventional imaging.
Zero-Delay Line Inversion: This physical shift repositions the zero-delay line from the vitreous down into the deep choroid, choriocapillaris, or sclerochoroidal junction.
Spectral Inversion: Software inverts the resulting Fourier spectrum, presenting the retina in its correct upright anatomical orientation while placing the region of peak sensitivity, highest SNR, and sharpest focus deep in the choroidal vascular beds and lamina cribrosa.
- Subfoveal Choroidal Thickness (SFCT) & The Pachychoroid Spectrum
- Measurement Protocol
Subfoveal choroidal thickness (SFCT) is measured on a high-resolution, averaged EDI horizontal B-scan passing directly through the foveal center:
Measurement Axis: A perpendicular caliper line drawn from the outer hyperreflective border of the RPE/Bruch's membrane complex down to the inner hyperreflective margin of the sclerochoroidal interface.
Physiological Baselines: In healthy young adults, normal SFCT averages 250 to 350 µm .
Physiological Variations:
Diurnal Variation: SFCT varies by 20 to 30 µm across 24 hours, being thickest in the early morning and thinnest in the late afternoon.
Age-Related Thinning: Normal choroidal thickness decreases predictably by approximately 15 to 20 µm per decade of life .
Axial Length / Myopia: SFCT decreases by approximately 15 to 25 µm for every millimeter increase in axial length. +-----------------------------------------------------------------------------------+
- | CHOROIDAL THICKNESS SPECTRUM IN CLINICAL DISEASE |
- +-----------------------------------------------------------------------------------+
- | THICK CHOROID: PACHYCHOROID SPECTRUM (SFCT >390 - 400 µm) |
- | - Central Serous Chorioretinopathy (CSCR): Dilated Haller pachyvessels, subretinal|
- | fluid, choriocapillaris attenuation, RPE decompensation |
- | - Pachychoroid Pigment Epitheliopathy (PPE): Asymptomatic RPE mottling over |
- | pachyvessels; precursor to CSCR |
- | - Pachychoroid Neovasculopathy (PNV): Type 1 shallow irregular choroidal |
- | neovascularization arising over focal choroidal thickening |
- | - Polypoidal Choroidal Vasculopathy (PCV): Aneurysmal dilatations / polyps of |
- | branching vascular network at choriocapillaris interface |
- +-----------------------------------------------------------------------------------+
- | THIN CHOROID: CHOROIDAL ATROPHY (SFCT <100 - 120 µm) |
- | - Pathologic / High Myopia: Posterior staphyloma, scleral stretching, extreme |
- | choroidal thinning (<60 µm), lacquer cracks |
- | - Age-Related Choroidal Atrophy (ARCA): Primary choroidal attenuation in advanced |
- | elderly patients; distinct from dry AMD |
- | - Geographic Atrophy (Dry AMD): Severe localized choroidal vascular loss beneath |
- | confluent RPE atrophy |
- +-----------------------------------------------------------------------------------+
- Hallmark Features of the Pachychoroid Spectrum
The hallmark of the pachychoroid spectrum on EDI-OCT is not merely global thickness, but the presence of pachyvessels —pathologically enlarged, engorged venous channels in Haller's layer that exert mechanical compression on the overlying Sattler's layer and choriocapillaris. This focal choriocapillaris ischemia and overlying RPE barrier breakdown lead to neurosensory detachments and subretinal fluid accumulation.
Lamina Cribrosa Visualization & Glaucomatous Structural Alterations
In open-angle and angle-closure glaucomas, the mechanical and vascular site of axonal injury is the lamina cribrosa (LC) within the optic nerve head. Because overlying prelaminar neural tissue, dense glial columns, and central retinal vessels scatter 840 nm light, conventional SD-OCT cannot clearly image laminar pores.
EDI-OCT enables direct visualization of both the anterior laminar surface and posterior laminar surface :
Laminar Thickness: Normal laminar thickness ranges from 250 to 300 µm; in eyes with advanced primary open-angle glaucoma, the lamina undergoes severe thinning to <150 µm.
Posterior Laminar Bowing: Elevated intraocular pressure (IOP) drives backward mechanical bowing of the cribriform plates, quantified as increased lamina cribrosa depth (LCD) relative to the reference plane of Bruch's membrane opening (BMO).
Focal Lamina Cribrosa Defects (FLCDs): EDI-OCT detects full-thickness holes, tears, or disinsertions in the laminar meshwork. These focal pores correspond directly to dense, localized visual field scotomas and recurring optic disc hemorrhages (Drance hemorrhages).
EDI-OCT in Choroidal Tumors: Nevus vs. Melanoma Differentiation
Evaluating small choroidal melanocytic lesions is a vital clinical application for EDI-OCT. Technologists utilize the TFSOM-UHHD mnemonic ( To Find Small Ocular Melanoma Using Helpful Hints Daily ), correlating clinical findings with cross-sectional EDI-OCT biomarkers:
Diagnostic Feature Benign Choroidal Nevus Malignant Choroidal Melanoma
Thickness (T) Typically flat or minimally elevated (<1.5 – 2.0 mm) Dome-shaped, collar-button, or mushroom elevation (>2.0 mm)
Fluid (F) Absent (dry retina over lesion) Subretinal Fluid (SRF): Pockets of fluid overlying or flanking tumor margin
Symptoms (S) Asymptomatic incidental finding Flashes, floaters, visual field deficits
Orange Pigment (O) Absent or faint drusen Hyperreflective Lipofuscin Clumps: Prominent orange clumps on RPE / hyper-FAF
Margin to Disc (M) Usually >3 mm from optic disc Often within 3 mm of optic disc margin
Ultrasound Hollowness (UH) High internal acoustic reflectivity Low-to-medium acoustic reflectivity ; internal vascular pulsations
Halo (H) Characteristic pigmented/depigmented circular halo Absent halo around actively expanding margin
Documented Growth (D) Structurally stable over serial exams Documented enlargement on sequential EDI-OCT/echography
EDI-OCT Optical Pattern Dense anterior hyperreflectivity with steep posterior shadowing Deep optical penetration, visible internal vascular spaces, overlying photoreceptor "shagginess"
Clinical Significance of Photoreceptor Shagginess: Chronic accumulation of subretinal fluid over an active melanoma prevents RPE phagocytosis of shed photoreceptor outer segments. On EDI-OCT, these outer segments elongate into irregular, hyperreflective finger-like projections termed "shaggy photoreceptors."
Anterior Segment OCT (AS-OCT): Instrumentation & Optical Modifications
While retinal OCT systems operate at ~840 nm to optimize resolution through the transparent ocular media, imaging the anterior segment presents different optical hurdles: dense scleral collagen fibers, pigmented iris stroma, and cloudy or edematous corneas induce extreme light scattering.
The 1310 nm Near-Infrared Wavelength Advantage
AS-OCT systems utilize a longer near-infrared center wavelength of approximately 1310 nm :
Reduced Optical Scattering: Rayleigh scattering is inversely proportional to the fourth power of wavelength ( ∼ 1 / λ 4 \sim 1/\lambda^4 ∼ 1/ λ 4 ). By increasing wavelength from 840 nm to 1310 nm, optical scattering in scleral and corneal collagen lamellae is reduced dramatically.
Water Absorption and Retinal Safety: Water within ocular media absorbs 1310 nm light strongly. Because 1310 nm photons are absorbed by aqueous and vitreous humors before reaching the retina, higher laser incident power (up to 10–20 times higher than retinal systems) can be safely directed into the anterior eye without causing photochemical retinal damage.
Imaging Depth: Permits complete cross-sectional imaging through the full thickness of the cornea, scleral spur, ciliary body, and crystalline lens surface.
Quantitative Anterior Chamber Angle Assessment
The fundamental anatomical landmark for all AS-OCT angle biometry is the scleral spur —the inward circular projection of the scleral sulcus marking the insertion of the longitudinal ciliary muscle fibers. +-----------------------------------------------------------------------------------+
- | AS-OCT ANTERIOR CHAMBER ANGLE BIOMETRY |
- +-----------------------------------------------------------------------------------+
- | Corneal Endothelium |
- | -------------------------- |
- | / \ |
- | / [AOD500] [AOD750] \ |
- | / | | \ |
- | [Scleral Spur (SS)] ->* | | \ |
- | \ | [TISA500] | [TISA750] |
- | \ | | \ |
- | \____v_______________v___________\ |
- | Anterior Iris Surface |
- +-----------------------------------------------------------------------------------+
- Standard Quantitative Angle Metrics
Trabecular-Iris Angle (TIA): The angle (measured in degrees) between the corneal endothelium/trabecular meshwork arm and the anterior iris surface, with the apex at the iridocorneal recess.
Angle Opening Distance at 500 µm and 750 µm (AOD500 / AOD750): The length of a perpendicular line originating from the trabecular meshwork at a point 500 µm (or 750 µm) anterior to the scleral spur, extending to meet the anterior iris surface.
Trabecular-Iris Space Area at 500 µm and 750 µm (TISA500 / TISA750): The trapezoidal area bounded anteriorly by the AOD500 (or AOD750) line, posteriorly by a line drawn perpendicular from the scleral spur to the iris, superiorly by the inner corneal wall, and inferiorly by the anterior iris surface.
Angle-Closure Mechanisms on AS-OCT
AS-OCT allows dynamic, dark-room non-contact classification of angle-closure glaucoma subtypes:
Pupillary Block: Manifests as pronounced anterior convex bowing of the iris ( iris bombé ) driven by relative pupillary resistance between the posterior and anterior chambers. Following laser peripheral iridotomy (LPI), the iris flattens immediately and the angle recess widens.
Plateau Iris Configuration: Characterized by a flat central iris plane, a deep central anterior chamber, and an abrupt, steep anterior angulation of the peripheral iris root caused by anteriorly rotated ciliary processes that physically prop the iris against the trabecular meshwork. The angle remains narrow or closed on AS-OCT even after a widely patent LPI.
Lens Vault (LV): Defined as the perpendicular distance from the anterior crystalline lens pole to the horizontal baseline connecting opposite scleral spurs. A high lens vault ( LV >600–800 µm ) indicates that the crystalline lens is the primary mechanical driver of angle crowding, directing treatment toward cataract extraction rather than iridotomy.
- AS-OCT Corneal Imaging & Surgical Evaluation
- Epithelial Thickness Mapping in Keratoconus and Ectasia
Modern AS-OCT generates 9 mm wide epithelial pachymetric maps. Normal central corneal epithelium is uniformly 50 to 55 µm thick. In subclinical or manifest keratoconus , the epithelium thins focally directly over the apex of the cone and thickens concentrically around the base, creating a pathognomonic "donut pattern" (epithelial donut). Detecting this epithelial redistribution prevents patients with subclinical ectasia from undergoing laser in situ keratomileusis (LASIK).
LASIK Flap and Corneal Cross-Linking (CXL) Evaluation
LASIK Flaps: AS-OCT measures flap thickness across the entire diameter, identifying flap thickness irregularities, microkeratome buttonholes, interface fluid syndrome, and epithelial ingrowth.
CXL Demarcation Line: At 1 month following riboflavin-UVA corneal collagen cross-linking for progressive keratoconus, AS-OCT reveals a sharp, hyperreflective horizontal band across the corneal stroma known as the demarcation line . Located typically at a depth of 250 to 320 µm , this line represents the biological boundary of cross-linked stroma and confirms adequate treatment depth while verifying endothelial safety (must remain >100 µm anterior to endothelium).
Lamellar Endothelial Keratoplasty (DSAEK and DMEK)
In Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) and Descemet Membrane Endothelial Keratoplasty (DMEK), AS-OCT provides immediate, non-contact evaluation of graft positioning in the early postoperative period:
Confirms complete graft adherence or identifies partial graft detachment and interface fluid.
Visualizes edge scroll separation, allowing targeted anterior chamber air or sulfur hexafluoride ( S F 6 SF_6 S F 6 ) rebubbling even when the host cornea is too cloudy or edematous for slit-lamp visualization.